Navigate Wealth Management LLC Acquires Shares of 2,971 Globe Life Inc. $GL

Navigate Wealth Management LLC acquired a new stake in shares of Globe Life Inc. (NYSE:GL) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,971 shares of the company’s stock, valued at approximately $448,000.

Other institutional investors have also recently made changes to their positions in the company. Compound Planning Inc. increased its stake in shares of Globe Life by 4.3% in the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after buying an additional 82 shares during the period. Root Financial Partners LLC raised its holdings in Globe Life by 23.3% during the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after buying an additional 83 shares during the last quarter. Transcend Capital Advisors LLC boosted its position in Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after buying an additional 84 shares during the period. Natural Investments LLC boosted its position in Globe Life by 2.6% during the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after buying an additional 87 shares during the period. Finally, Parallel Advisors LLC boosted its position in Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after buying an additional 87 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling at Globe Life

In other news, CEO Frank M. Svoboda sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.59, for a total value of $1,242,698.24. Following the sale, the chief financial officer owned 50,496 shares in the company, valued at $7,907,168.64. This represents a 13.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 124,187 shares of company stock worth $19,529,414. Insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on GL. Wells Fargo & Company boosted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday. Piper Sandler increased their target price on shares of Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Morgan Stanley boosted their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. Finally, Jefferies Financial Group upped their price target on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.70.

Globe Life Stock Down 0.0%

Shares of NYSE GL opened at $179.10 on Monday. The firm has a fifty day simple moving average of $163.71 and a two-hundred day simple moving average of $150.24. Globe Life Inc. has a 12 month low of $117.30 and a 12 month high of $182.32. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $13.91 billion, a PE ratio of 12.39 and a beta of 0.47.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $3.07 EPS. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts expect that Globe Life Inc. will post 15.64 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.